This site is intended for health professionals only
Hospital Healthcare Europe
Register
Login
Linkedin
Facebook
Select Language
English
French
German
Italian
Spanish
News
In depth
Views
Conference reports
Reviews & Research
Practice
Health technology
Sustainability
Clinical
Cardiovascular
Dermatology
Emergency and critical care
Gastroenterology
Haematology
Immunology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Events
Upcoming events
On-demand learning
Clinical Excellence Catch-up
Partners
Register
Login
News
In depth
Views
Conference reports
Reviews & Research
Practice
Health technology
Sustainability
Clinical
Cardiovascular
Dermatology
Emergency and critical care
Gastroenterology
Haematology
Immunology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Events
Upcoming events
On-demand learning
Clinical Excellence Catch-up
Partners
Register
Login
Home
>
Editor’s pick
Editor’s pick
Drug eases chemotherapy side effects
Fatal condition linked to genes
UCB seeking to acquire remaining Schwarz Pharma shares
Sun announces Uroxatral approval
A novel approach to the management of COPD
EU approves Glivec in bid to reduce cancer casualties
Genzyme further expands biomanufacturing plant in Belgium
Arpida AGM of shareholders approves all Board proposals
Newron start work on SETTLE1 study
Arpida to discuss strategy with shareholders
First eczema treatment granted UK license
Glaxo set to sell Wellbutrin XL brand
« Previous
1
…
139
140
141
142
143
…
302
Next »
Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
x
Search for: